HMD.AX Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (2 bal. 2024 @ 07:50):

HeraMED Limited, together with its subsidiaries, develops, manufactures, and sells foetal heart beat monitors and other pregnancy monitoring solutions for home use in Australia, Europe, and Israel...

Stats
Dzisiejszy wolumen	396 047
Średni wolumen	147 217
Kapitalizacja rynkowa	6.55M
Następna data zysków	( $0 ) 2024-05-30
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.570
ATR14	$0 (0.00%)

Hera Med Ltd Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Hera Med Ltd Finanse

Annual	2023
Przychody:	$606 986
Zysk brutto:	$-300 006 (-49.43 %)
EPS:	$-0.0255

FY	2023
Przychody:	$606 986
Zysk brutto:	$-300 006 (-49.43 %)
EPS:	$-0.0255

FY	2022
Przychody:	$315 789
Zysk brutto:	$-314 150 (-99.48 %)
EPS:	$-0.0322

FY	2021
Przychody:	$86 654.00
Zysk brutto:	$44 406.00 (51.25 %)
EPS:	$-0.0454

Financial Reports:

No articles found.

Hera Med Ltd

HeraMED Limited, together with its subsidiaries, develops, manufactures, and sells foetal heart beat monitors and other pregnancy monitoring solutions for home use in Australia, Europe, and Israel. The company provides HeraBEAT, a fetal heart rate monitor use by an expectant mother to monitor their fetus' heartbeat; and HeraCARE, a digital pregnancy monitor platform for the creation and implementation of digital health solutions for maternity care management. It also develops EchoBEAT, the next generation of its home-oriented pregnancy monitoring devices; and Orion, an artificial intelligence powered pregnancy monitoring system for pregnancy monitoring analysis. The company has a collaboration agreement with Mayo Clinic for the development of its HeraCARE pregnancy management platform. HeraMED Limited was incorporated in 2011 and is headquartered in Netanya, Israel.